Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Recruiting 10Completed 4Not yet recruiting 3Active not recruiting 3Terminated 2Suspended 1Enrolling by invitation 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 1CNS 1

Conditions

Neoplasms 1Motor Activity 1Hematologic Neoplasms 1Depression 1Central Nervous System Neoplasms 1

Interventions

pembrolizumab 111Carboplatin 45Nivolumab 41Paclitaxel 34Cyclophosphamide 32Cisplatin 32Gemcitabine 30atezolizumab 27Specimen Handling 25venetoclax 24Magnetic Resonance Spectroscopy 24Pemetrexed 23fludarabine 22Biopsy 22Radiotherapy 21Ipilimumab 21Docetaxel 21Bevacizumab 21Azacitidine 21Radiosurgery 18durvalumab 17Fluorouracil 17Dexamethasone 17Cetuximab 16fludarabine phosphate 14Trastuzumab 14Leucovorin 13Cytarabine 13tislelizumab 12olaparib 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Focus Groups × 1 year × Clear all
NCT05012124 2026-04-16

Using Technology to Optimize Collaborative Care Management of Depression in Urban and Rural Cancer Centers, SCOPE

University of Washington

Phase NA Terminated
297 enrolled
Other hematologic neoplasm

Depression, Hematologic Neoplasms

NCT05308407 2025-08-05

POWER UP: Participating Online While Exercising to Recover Using Play

M.D. Anderson Cancer Center

Phase NA Terminated
17 enrolled
CNS

Motor Activity, Neoplasms, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡